READ'S PHARMACY LIMITEDActive

Company number 00185402Private limited companyIncorporated 1922

Key figures

£3,805,470-6.2%
Net assets 2024/25
-2.8%
Average annual change 2019/20–2024/25
02 m4 m6 m2019/202020/212021/222022/232023/242024/25

Like most small UK companies, READ'S PHARMACY LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
02 m4 m6 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand226,258879,933205,018165,975116,120
Total assets5,167,1394,965,1124,440,7304,499,3824,296,269
Total liabilities60,075119,16583,89045,42555,273
Net assets / total equity4,778,3394,541,1243,958,1254,055,6223,805,470
Average number of employees22222

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: READ'S PHARMACY LIMITED

Company

READ'S PHARMACY LIMITED is a private limited company registered with Companies House under company number 00185402. It was incorporated on 31 Oct 1922. Its status is active. The registered office is in Norfolk (NR16). Its nature of business (SIC 2007) is other letting and operating of own or leased real estate (68209).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Oct 2025); the company files small company accounts (filleted). Net assets were £3,805,470, down 6.2% on the previous year. Cash at bank and in hand was £116,120. Total assets were £4,296,269 and total liabilities £55,273. The company had an average of 2 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

The company has 2 current directors. One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Jul 2027. The next confirmation statement is due by 14 Nov 2026.